Rochester, Minn.-based Mayo Clinic has selected 31 digital health companies for its largest Mayo Clinic Platform Accelerate cohort to date, including six developing AI-powered solutions to support clinicians and patient care.
The companies will gain access to Mayo Clinic Platform’s de-identified clinical data ecosystem, mentorship from Mayo Clinic experts and educational resources to advance their technologies, according to an Oct. 28 news release Mayo shared with Becker’s.
Six companies will participate in the program’s multiyear pathway, which provides up to two years of access to Mayo Clinic Platform’s data environment, advisors and technical support. The pathway is designed to support continued technology development and potential real-world deployment.
The six companies are A.I. VALI, Cardio AI Live, DxDepth, FluidAI Medical, GRAIMED and Healthplus.ai.
The remaining 25 companies will participate in a 30-week accelerator program focused on advancing data-driven healthcare technologies through clinical data access, structured education and one-on-one technical mentorship.
Since launching in 2022, Mayo Clinic Platform Accelerate has supported more than 130 digital health companies worldwide.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
